On a tight watch list for tomorrow and for DSCO on Thursday. FDA approval for Surfaxin on Thursday comes in for DSCO. The stock could jump or drop 25-50% on the announcement.
This blog is for informational purposes only. It does not give investment advice.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment